Company / Profit Margin
Syndax Pharmaceuticals Inc Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-165.6%
FY2025
5-year range
-3694.6% / -165.6%
FY2021-FY2025
Trend
+87.7%
vs FY2024
Sector context
#107 of 146
Health Care
What the data says
At -165.6%, Syndax Pharmaceuticals Inc's profit margin ranks #107 of 146 in the Health Care sector. Profit Margin has increased for 3 consecutive years, from -4875.5% in FY2020 to -165.6% in FY2025.
Based on SEC 10-K filings.
-165.6% in FY2025 with a 5-year CAGR of +4709.9%.
Improved from -3694.6% to -165.6% over the past 4 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- +4709.9pp
- 10-Year Change
- -
Sector benchmark
#107 of 146 in Health CareTop 73% of 146This company -165.6% Sector average -796.3%
▼
+79.2% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 87.7% year-over-year.
- Currently 630.7pp above the Health Care sector average.
- Lowest profit margin in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -165.6% | +87.7% |
| FY2024 | -1346.1% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | -3694.6% | +24.2% |
| FY2020 | -4875.5% | -69.0% |
| FY2019 | -2884.3% | +20.9% |
| FY2018 | -3645.3% | +5.2% |
| FY2017 | -3846.7% | -21.6% |
| FY2016 | -3162.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026